Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Roche Holding AG's share price for the quarter that ended in Dec. 2023 was $36.23. Roche Holding AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 6,378 Mil. Therefore, Roche Holding AG's market cap for the quarter that ended in Dec. 2023 was $231,073 Mil.
Roche Holding AG's quarterly market cap
declined
from Dec. 2022 ($250,304 Mil) to Jun. 2023 ($244,068 Mil) and
declined
from Jun. 2023 ($244,068 Mil) to Dec. 2023 ($231,073 Mil).
Roche Holding AG's annual market cap
declined
from Dec. 2021 ($330,983 Mil) to Dec. 2022 ($250,304 Mil) and
declined
from Dec. 2022 ($250,304 Mil) to Dec. 2023 ($231,073 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Roche Holding AG's Enterprise Value for Today is $218,151 Mil.
Roche Holding AG Market Cap Historical Data
The historical data trend for Roche Holding AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Roche Holding AG Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Market Cap
278,360.39
299,208.44
330,982.96
250,303.57
231,072.77
Roche Holding AG Semi-Annual Data
Jun14
Dec14
Jun15
Dec15
Jun16
Dec16
Jun17
Dec17
Jun18
Dec18
Jun19
Dec19
Jun20
Dec20
Jun21
Dec21
Jun22
Dec22
Jun23
Dec23
Market Cap
330,982.96
267,137.12
250,303.57
244,067.82
231,072.77
Competitive Comparison
For the Drug Manufacturers - General subindustry, Roche Holding AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Roche Holding AG Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Roche Holding AG's Market Cap falls into.
Roche Holding AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Roche Holding AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Roche Holding AG (OTCPK:RHHBY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Roche Holding AG Market Cap Related Terms
Thank you for viewing the detailed overview of Roche Holding AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Roche Holding AG (Roche Holding AG) Business Description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RHHBY has been successfully added to your 